Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial.
about
Review of health-related quality of life data in multiple myeloma patients treated with novel agents.Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide.A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial.Quality of life and supportive care in multiple myeloma.Novel anticancer agents for multiple myeloma: a review of the evidence for their therapeutic and economic value.Subcutaneous bortezomib for multiple myeloma treatment: patients' benefits.Optimizing quality of life in multiple myeloma patients: current options, challenges and recommendations.A systematic review of health-related quality of life in longitudinal studies of myeloma patients.Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry.Patient-Reported Physical Function Measures in Cancer Clinical Trials.Multiple myeloma: an update.Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry.Quality of life and symptoms in patients with malignant diseases admitted to a comprehensive cancer centre.United Kingdom Myeloma Forum position statement on the use of consolidation and maintenance treatment in myeloma.Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial.
P2860
Q30650394-D66B9642-B47D-4AF4-B0AD-0A954E139C21Q35669893-91BE208A-5E2F-4ED8-98D8-5A21444372AEQ36654092-3B15D5FC-51D8-4CF1-9E5A-DEBC619B0EA8Q37426566-8C4E0334-74B7-40A6-AEF5-7D680E2D6204Q38020248-85537322-CE7B-4D94-98D4-F3DFA4146727Q38232055-4AFDE3DC-3576-4D9B-A846-A9BCA094A6EDQ38367654-0B70D48A-0066-4C84-BDE8-12AAAC05C85AQ38742505-A09582E3-3625-4C9E-9455-46F58565CFCAQ39084538-CC52EF37-DD7F-44F7-BFC0-56454729C573Q39270037-AAAEA2AD-C651-4FA5-A97E-A01F2A1C02E8Q39471739-B3C96381-385A-4E43-9A8A-18C81AD8E6D1Q39591636-1612AB1A-88F5-4162-A0E1-F8054A11B952Q45514142-C3D0FB8D-F7A2-476F-B2A2-018B098441BFQ46779037-660869D2-4894-4F7F-81F1-693968A98DCCQ48459753-28F77885-B2F0-4B82-8073-EBE33035226E
P2860
Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Effect of thalidomide with mel ...... nalysis in a randomized trial.
@en
Effect of thalidomide with melphalan and prednisone on health-related quality of life
@nl
type
label
Effect of thalidomide with mel ...... nalysis in a randomized trial.
@en
Effect of thalidomide with melphalan and prednisone on health-related quality of life
@nl
prefLabel
Effect of thalidomide with mel ...... nalysis in a randomized trial.
@en
Effect of thalidomide with melphalan and prednisone on health-related quality of life
@nl
P2093
P2860
P1433
P1476
Effect of thalidomide with mel ...... nalysis in a randomized trial.
@en
P2093
A H M Ammerlaan
C A Uyl-de Groot
Dutch-Belgium Hemato-Oncology Cooperative Group (HOVON)
F Termorshuizen
H A M Sinnige
H M Lokhorst
M R Schaafsma
M van Marwijk Kooy
P Sonneveld
P W Wijermans
P2860
P304
P356
10.1007/S00277-011-1224-1
P577
2011-04-07T00:00:00Z